HSC01
clear graphic clear graphic
clear graphic

Insomnia? How better sleep may help cancer patients (and everyone else)

Posted on Tuesday, June 12, 2012


clear graphicclear graphic
clear graphicclear graphic
clear graphicEmail Printer Friendly Format
 

Contact: Elizabeth Allen, CTRC, 210-450-2020

SAN ANTONIO (June 12, 2012) – Everyone needs a good night’s sleep, but cancer patients often have extra hurdles between them and healing slumber, while their need for it is even more vital.

Three experts will address these issues Thursday evening at the Cancer Therapy & Research Center’s free public lecture on sleep problems, ways to deal with them, and the importance of sleep to overall good health.

Angela Velez, M.D., assistant professor of neurology in the School of Medicine, will talk about insomnia and available treatments as well as periodic leg movements and sleep apnea, as those disorders are common in cancer patients. Amy Arisco, M.D., assistant professor of urology, will focus on nocturia, or frequent nighttime urination, and tips on managing it. Wendy Crabbe, RN, MSN, will address fatigue, psychosocial issues and pain management as they relate to sleep problems.

The lecture, which is open to the public and has a question-and-answer session, will be Thursday, June 14 from 6 to 7:30 p.m. on the fourth floor of the CTRC’s Grossman Building, 7979 Wurzbach Rd., San Antonio. For more information call (210) 450-1152. It will be streamed live online at www.CTRC.net/LIVE. The lecture is also sponsored by H-E-B and the Institute for the Integration of Medicine and Science at the UT Health Science Center San Antonio.

###


The Cancer Therapy & Research Center (CTRC) at The University of Texas Health Science Center at San Antonio is one of the elite academic cancer centers in the country to be named a National Cancer Institute (NCI) Designated Cancer Center, and is one of only four in Texas. A leader in developing new drugs to treat cancer, the CTRC Institute for Drug Development (IDD) conducts one of the largest oncology Phase I clinical drug programs in the world, and participates in development of cancer drugs approved by the U.S. Food & Drug Administration. For more information, visit www.ctrc.net.

 
Share |


bottom bar

»printer friendly format...
»view more articles by issue#...
»search articles by keywords...
Arrow - to top
Arrow - to top